Managers / Q3 2020 · view latest →
Norwest Venture Partners XII, LP
CIK 0001614660 · 525 UNIVERSITY AVENUE, SUITE 800, PALO ALTO, CA, 94301 · 650-321-8000
Summary
Norwest Venture Partners Xii, LP reported $46M in U.S.-listed holdings across 2 positions for Q3 2020.
The portfolio is heavily concentrated: HCAT alone accounts for 69.7% of reported value.
The book was largely unchanged from Q2 2020.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 69.7% · $32M
- Other · 30.3% · $14M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HCATHealth Catalyst, Inc. | TRIMMED | −1.48M | 876.0K | −$37M | $32M |
| Casper Sleep Inc. | HELD | +0 | 1.94M | −$3M | $14M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HCATHealth Catalyst, Inc.history → | COM | 69.68% | $32M | 876.0K |
| 2 | Casper Sleep Inc. | COM | 30.32% | $14M | 1.94M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2022 | $75M | 2 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $96M | 2 | Jul 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $157M | 2 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $258M | 3 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $46M | 2 | Oct 23, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $86M | 2 | Jul 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $62M | 1 | Apr 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $102M | 1 | Feb 4, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.